Price
No data yet.
Social Signal Score
Analyst Ratings
1 analystRevenue
$9.51MAnalyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Larry C. Heaton II
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 144
- Beta
- 1.16
- Country
- US
- Piotroski score
- 2 / 9 (Weak)
- Altman Z-score
- 1.83
Financials
Revenue
$9.51M+67246.4%Net Income
$-3.77MEBITDA
$-4.08MFree Cash Flow
$-2.55MEPS (diluted)
$-0.00Shares Outstanding (diluted)
979.95M+1108.7%Operating Expenses
$10.12MCash & Debt
$44.13MReturn of Capital
$0.00Revenue by Segment (annual)
$29.00MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2026 | $32.03M | $-81.86M | $-0.08 |
| 2025 | $27.29M | $-46.98M | $-0.05 |
| 2024 | $25.19M | $-34.53M | $-0.04 |
| 2023 | $18.93M | $-17.02M | $-0.02 |
| 2022 | $4.13M | $-18.38M | $-0.02 |
| 2021 | $0.00 | $-16.92M | $-0.05 |
| 2020 | $0.00 | $-19.82M | $-0.19 |
| 2019 | $0.00 | $-16.65M | $-0.18 |
| 2018 | $0.00 | $-8.07M | $-0.09 |
| 2017 | $0.00 | $-6.01M | $-0.07 |
| 2016 | $0.00 | $-2.28M | $-0.05 |
| 2015 | $0.00 | $-42.4K | $-0.04 |
| 2014 | $0.00 | $-77.5K | $-0.23 |
Valuation
ZOMhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
120+20.00%Social Signal Score
Mentions (4)
- Newsseekingalpha.com·10d ago·Positive
Zomedica Corp. (ZOMDF) Inside Marketing: How Demand Creation Drives Revenue and Supports Distinct Product Portfolios Transcript Zomedica Corp. (ZOMDF) Inside Marketing: How Demand Creation Drives Revenue and Supports Distinct Product Portfolios Transcript
View source ↗ - Newsaccessnewswire.com·27d ago·Neutral
…ield, and supports utilization across the company's diagnostic and therapeutic portfolios ANN ARBOR, MI / ACCESS Newswire / September 9, 2026 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the next installment of its "Fourth Friday at Four" investor webinar series, scheduled for Friday, September 25, 2026, at 4:00 p.m. Eastern Time.
View source ↗ - Newsseekingalpha.com·38d ago·Positive
Zomedica Corp. (ZOMDF) Q2 2026 Earnings Call Transcript Zomedica Corp. (ZOMDF) Q2 2026 Earnings Call Transcript
View source ↗ - Newsaccessnewswire.com·56d ago·Neutral
Zomedica Announces "Fourth Friday at Four" Webinar on August 28, 2026: Zomedica International: Building a Global Platform for Veterinary Innovation August session to spotlight Zomedica's international expansion strategy, distributor infrastructure, global market opportunity, and the commercial leadership driving growth across five continents ANN ARBOR, MI / ACCESS Newswire / August 11, 2026 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative
View source ↗
Earnings
Typical surprise +0.0% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Mar 13$-0.01 vs $-0.01beat
Estimates and results for ZOM via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ZOM officers and directors.
- Bought
- $995k
- Sold
- $564k
56 trades
2 trades
- Rowe Jeffrey Mbought
- Rowe Jeffrey Mbought
- Rowe Jeffrey Mbought
- Rowe Jeffrey Mbought
- Rowe Jeffrey Mbought
- Rowe Jeffrey Mbought
- Williams Rodney Jamesbought
- Jordan Scottbought
42 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in ZOM.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.